Regulatory News :
BioAlliance Pharma SA (Paris:BIO) (Euronext Paris - BIO), an innovative Company dedicated to the development of orphan oncology products and to supportive care products, today published the major key milestones achieved during the third quarter of 2013.
Help employers find you! Check out all the jobs and post your resume.
